Real-time enrollment status for this plasma cell myeloma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:35 AM UTC
| NCT Number | NCT04211259 |
| Recruiting Status | Recruiting |
| Condition | Plasma Cell Myeloma |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 70 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Rutgers, The State University of New Jersey |
| Last Updated on CT.gov | May 29, 2026 (May 29, 2026) |
As of July 19, 2026: Clinical trial NCT04211259 is currently recruiting participants. This early_phase1 study for plasma cell myeloma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Rutgers, The State University of New Jersey. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04211259 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04211259 was last updated May 29, 2026 (May 29, 2026). HelloStudys verifies this status automatically.